๐ฐ Mark Neumann News
Page 3 - Mark Neumann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Neumann. Real-time updates on events, politics, business and more.
October 31, 2023
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s share price was up 6.7% during trading on Tuesday . The company traded as high as $49.48 and last traded at $49.46. Approximately 782,313 shares were traded during trading, an increase of 4% from the average daily volume of 752,862 shares. The stock had previously closed at […]
October 29, 2023
Handelsbanken Fonder AB grew its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 30.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,400 shares of the biopharmaceutical company’s stock after purchasing an additional 3,600 shares during […]
October 29, 2023
Arizona State Retirement System decreased its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,086 shares of the biopharmaceutical company’s stock after selling 611 shares during the period. Arizona […]
October 28, 2023
Oklahoma City -- The Brightmusic Chamber Ensemble on Tuesday evening, November 14, will present “Fantasy for Clarinets” The concert will feature Mozart, Mendelssohn, Martinลฏ, and a commissioned piece.Daniel Gilbert returns
October 19, 2023
Read CNNโs Fast Facts about Scott Walker and learn more about the former governor of Wisconsin.
October 5, 2023
Vahanian & Associates Financial Planning Inc. reduced its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 15,217 shares of the biopharmaceutical company’s stock after selling 915 shares during the period. Intra-Cellular Therapies makes up […]
September 23, 2023
Harbor Capital Advisors Inc. bought a new stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 734 shares of the biopharmaceutical company’s stock, valued at approximately $46,000. A number of other hedge […]
September 20, 2023
DnB Asset Management AS lifted its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 41.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,273 shares of the biopharmaceutical company’s stock after buying an additional 4,151 shares during […]
September 5, 2023
AlphaCentric Advisors LLC lifted its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 240.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,500 shares of the biopharmaceutical company’s stock after acquiring an additional 18,000 shares during the quarter. […]
September 2, 2023
Miramar Capital LLC lifted its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,550 shares of the biopharmaceutical company’s stock after buying an additional 555 shares during the […]